| 000 | 01811 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515010256.0 | ||
| 264 | 0 | _c20060207 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0953-816X | ||
| 024 | 7 |
_a10.1111/j.1460-9568.2005.04503.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEricson, Cecilia | |
| 245 | 0 | 0 |
_aEx vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bThe European journal of neuroscience _cDec 2005 |
||
| 300 |
_a2755-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphetamine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAstrocytes _xphysiology |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aCell Transplantation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor _xgenetics |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLentivirus _xgenetics |
| 650 | 0 | 4 |
_aNerve Fibers _xphysiology |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aStereotyped Behavior _xdrug effects |
| 650 | 0 | 4 |
_aSubstantia Nigra _xcytology |
| 650 | 0 | 4 | _aSympatholytics |
| 650 | 0 | 4 | _aTransduction, Genetic |
| 700 | 1 | _aGeorgievska, Biljana | |
| 700 | 1 | _aLundberg, Cecilia | |
| 773 | 0 |
_tThe European journal of neuroscience _gvol. 22 _gno. 11 _gp. 2755-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1460-9568.2005.04503.x _zAvailable from publisher's website |
| 999 |
_c15946299 _d15946299 |
||